Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3.
about
Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibitionThe role of MEKK1 in hypertrophic cardiomyopathy.Exercise training reduces fibrosis and matrix metalloproteinase dysregulation in the aging rat heart.Association between plasma ADAMTS-7 levels and ventricular remodeling in patients with acute myocardial infarction.Acute actions and novel targets of matrix metalloproteinases in the heart and vasculatureTIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice.Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.Circulating matrix metalloproteinase-2 and -9 enzyme activities in the children with ventricular septal defect.Elastin overexpression by cell-based gene therapy preserves matrix and prevents cardiac dilation.Pheochromocytoma-induced cardiomyopathy is modulated by the synergistic effects of cell-secreted factors.Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodellingTargeting fibrosis for the treatment of heart failure: a role for transforming growth factor-β.Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodelling.Cardiac Physiology of Aging: Extracellular Considerations.Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice.Microcurrent stimulation promotes reverse remodelling in cardiomyocytesTissue inhibitor of matrix metalloproteinase-3 or vascular endothelial growth factor transfection of aged human mesenchymal stem cells enhances cell therapy after myocardial infarction.Tissue inhibitor of metalloproteinase-1 and -3 improves cardiac function in an ischemic cardiomyopathy model rat.The Role of ADAMTS1 and Versican in Human Myocardial Infarction: A Postmortem Study.TGF-beta 1 attenuates myocardial ischemia-reperfusion injury via inhibition of upregulation of MMP-1.Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts.Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction.Inhibiting matrix metalloproteinase by cell-based timp-3 gene transfer effectively treats acute and chronic ischemic cardiomyopathy.Tissue inhibitor of metalloproteinase-3 inhibits neonatal mouse cardiomyocyte proliferation via EGFR/JNK/SP-1 signaling.Effects of autologous stem cells on immunohistochemical patterns and gene expression of metalloproteinases and their tissue inhibitors in doxorubicin cardiomyopathy in a rabbit model.Utility of Glycosylated TIMP3 molecules: Inhibition of MMPs and TACE to improve cardiac function in rat myocardial infarct model
P2860
Q33650887-029011A4-D8FD-4663-9565-CC501D52D07FQ34286589-ED3621CE-6881-4522-A85E-BFC6EB7B3E16Q34592384-D1D5DE27-427D-48B7-A539-1BE7D432D5D4Q35379826-A1F498F4-0570-42F0-A9D6-4146AD231727Q35995215-5510B0A3-A912-4098-ABE3-CDFB6B803761Q36106449-C555743E-A3A8-4076-8687-48A3AEF4992CQ36915712-0766A062-B384-4B96-8F32-D5933EEA72CBQ37001501-DE69C3C8-A75B-48B4-88DA-6ABB79BFEC6CQ37296231-52941C35-81B4-4CAF-9A94-07A59D5FB493Q37403704-2FFA752B-3FEE-4D2B-B1D2-029973A2BB31Q37580740-B5F7D773-3643-4D4A-ACCD-5FFC77BA6BFEQ37924999-AE7ECCC9-81BA-47C2-B37B-5B02D0D2DF0EQ37969775-EE7AA7D5-8032-473D-A718-E12280B416DEQ38542448-F83A6DF9-88DA-48E1-81C0-F9CF5A6ED186Q38584976-8E7BDB8A-CA82-4120-A300-BA1CCAE28EE5Q39256520-7AAADCBA-E9AD-43AC-AA15-0EB079CAE048Q41672067-46FCF00A-9C67-42AD-89E1-9BE4573ACC9BQ41825669-8B265604-12BC-4651-9015-671E8B50A01FQ42004537-6C82124A-84F8-413D-B028-F9C460F5F106Q44392710-B7CCA003-7D72-4C89-A1C5-14B206BD2368Q45223757-A4AA7E80-747C-4A20-9993-A67FC41EA89AQ45858813-C883FE10-A0C2-4ACD-AB3E-E4CDBE76E876Q45873510-531E1513-A6B7-4558-B13E-61576AB9496BQ46124568-96269E92-66AE-418B-8924-521905537600Q50689194-FE9531FB-F83B-46D1-AC37-D9F93EAFB833Q59136160-CE2728AF-190B-4DB8-95F5-C417C1CFB762
P2860
Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Matrix remodeling in experimen ...... le regulatory role for TIMP-3.
@en
Matrix remodeling in experimen ...... le regulatory role for TIMP-3.
@nl
type
label
Matrix remodeling in experimen ...... le regulatory role for TIMP-3.
@en
Matrix remodeling in experimen ...... le regulatory role for TIMP-3.
@nl
prefLabel
Matrix remodeling in experimen ...... le regulatory role for TIMP-3.
@en
Matrix remodeling in experimen ...... le regulatory role for TIMP-3.
@nl
P2093
P2860
P1476
Matrix remodeling in experimen ...... le regulatory role for TIMP-3.
@en
P2093
Bradley H Strauss
Chris Kiani
Donald A G Mickle
Nafiseh Nili
Nobuhisa Ohno
Paul W M Fedak
Richard D Weisel
Subodh Verma
Svetlana M Altamentova
P2860
P304
P356
10.1152/AJPHEART.00684.2002
P577
2002-10-10T00:00:00Z